SCHEMBL23463196

SCHEMBL23463196

Bc1ccc2c(c1)C(C)(C)OC2

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PGR P06401 9/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16172610 0.78 SLC5A1 (0.34) PGR
SCHEMBL18474236 0.76 PGR (0.45) PGR
SCHEMBL9727613 0.76 OPRM1 (0.41)
SCHEMBL309789 0.76 KDM1A (0.36) PGR
SCHEMBL12680664 0.73 ALDH1A1 (0.35) PGR
SCHEMBL17591368 0.73 DRD2 (0.39)
SCHEMBL15147627 0.72 KDM1A (0.41) PGR
SCHEMBL309301 0.72 ALDH1A1 (0.38) PGR
SCHEMBL24822914 0.71 HTT (0.32) PGR
SCHEMBL23714893 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3827830-A1 COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE Janssen Pharmaceutica NV (BE) 2021-06-02 EP disclosed